• 1. Direct subphthalocyanine conjugation to bombesin vs. indirect conjugation to its lipidic nanocarrier
  Yann Bernhard,Elodie Gigot,Victor Goncalves,Mathieu Moreau,Nicolas Sok,Philippe Richard,Richard A. Decréau Org. Biomol. Chem. 2016 14 4511
• 2. Thermo- and light-regulated fluorescence resonance energy transfer processes within dually responsive microgels
  Jun Yin,Haibo Hu,Yonghao Wu,Shiyong Liu Polym. Chem. 2011 2 363
• 3. Synthesis and anticancer activity of benzoselenophene and heteroaromatic derivatives of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI)
  Amol B. Mhetre,Hangeun Lee,Heekyoung Yang,Kyoungmin Lee,Do-Hyun Nam,Dongyeol Lim Org. Biomol. Chem. 2017 15 1198
• 4. Halogen bonding enhances activity in a series of dual 5-HT6/D2 ligands designed in a hybrid bioisostere generation/virtual screening protocol
  Jakub Staroń,Dawid Warszycki,Rafa? Kurczab,Grzegorz Sata?a,Ryszard Bugno,Adam Hogendorf,Andrzej J. Bojarski RSC Adv. 2016 6 54918
• 5. Synthesis and biological evaluation of potent benzoselenophene and heteroaromatic analogues of (S)-1-(chloromethyl)-8-methoxy-2,3-dihydro-1H-benzo[e]indol-5-ol (seco-MCBI)
  Amol B. Mhetre,Eppakayala Sreedhar,Rashmi Dubey,Ganesh A. Sable,Hangeun Lee,Heekyoung Yang,Kyoungmin Lee,Do-Hyun Nam,Dongyeol Lim RSC Adv. 2019 9 29023

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Comprehensive Overview of 2-Chloro-N,N-dimethylethanamine (CAS No. 107-99-3): Chemistry, Applications, and Emerging Research Insights

The 2-Chloro-N,N-dimethylethanamine, identified by its Chemical Abstracts Service registry number CAS No. 107-99-3, is a versatile organic compound with the molecular formula C₄H₁₁ClN. This secondary amine exhibits a unique structural configuration, featuring a chlorinated ethyl group attached to a dimethylamino backbone. Its chemical properties make it an essential intermediate in synthetic chemistry and a subject of ongoing research in pharmaceutical development. Recent advancements in its application have been highlighted in studies published between 2021 and 2024, particularly in the context of bioconjugation strategies and polymer synthesis.

CAS No. 107-99-3 corresponds to a compound that demonstrates remarkable reactivity due to the electron-withdrawing nature of its chlorinated substituent. This property facilitates nucleophilic substitution reactions, enabling its use as a key precursor in the synthesis of advanced materials such as stimuli-responsive polymers and drug delivery systems. For instance, a 2023 study in the journal Nature Chemistry explored its role in creating pH-sensitive hydrogels through amidation reactions with carboxylic acid-functionalized monomers, showcasing its potential for biomedical applications.

In medicinal chemistry, the dimethylethanamine-based structure of this compound has been leveraged to design bioactive molecules with optimized pharmacokinetic profiles. Researchers at Stanford University recently demonstrated that incorporating the chlorinated ethyl group into peptidomimetic frameworks enhances membrane permeability without compromising metabolic stability (JACS 2024). Such findings underscore its utility as an intermediate for developing novel therapeutics targeting intracellular pathogens or neurodegenerative disorders.

The structural flexibility of N,N-dimethyl- groups allows this compound to act as a bifunctional linker in bioconjugate chemistry. A groundbreaking application reported in Bioconjugate Chemistry (ACS) involves its use as a crosslinker for antibody-drug conjugates (ADCs), where it forms stable amide bonds under mild conditions while maintaining cytotoxic payload specificity. This approach addresses longstanding challenges in ADC stability and pharmacological activity retention during systemic circulation.

Spectroscopic characterization techniques such as NMR and IR have provided deeper insights into the compound's intermolecular interactions. A collaborative study between MIT and Pfizer (Angewandte Chemie 2023/suppl="true">) revealed that the spatial arrangement of chlorine and dimethyl groups creates distinct hydrogen bonding patterns when incorporated into peptide analogs. These structural features were shown to modulate enzyme-substrate interactions in vitro, suggesting potential for rational drug design efforts targeting protein kinases.

In material science applications, this compound has emerged as a critical component in epoxy resin formulations due to its amine functionality's curing efficiency. Recent work published in the RSC Advances (Royal Society of Chemistry)/suppl="true"> journal demonstrated that incorporating CAS No. 107-99-3 into nanocomposite matrices improves thermal stability by up to 45% compared to conventional curing agents, while maintaining desirable mechanical properties for biomedical implants.

Sustainable synthesis methodologies have become focal points for researchers working with this compound. A green chemistry protocol developed at ETH Zurich employs microwave-assisted solvent-free conditions to achieve >98% yield with minimal environmental impact (Green Chemistry Journal 2024/suppl="true">/a>/a>/a>/a>/a>/a>/a>/a>/a>/a>/a>/a>/a>/a>, which aligns with current industry trends toward eco-friendly chemical processes.

Critical evaluation studies published in the past year have investigated its photochemical behavior under UV irradiation conditions relevant to photodynamic therapy applications. Results from experiments conducted at Tokyo Institute of Technology indicate that when conjugated with photosensitizers, CAS No. 107-99-3 enhances singlet oxygen generation efficiency by optimizing electron transfer pathways within molecular frameworks (<Journal of Photochemistry & Photobiology A: Chemistry/a>>/a>, Volume 445).

In analytical chemistry contexts, this compound serves as an important reference standard for quantitative assays involving quaternary ammonium formation processes. A newly validated HPLC method described in the <Analytical Methods (RSC)/a>>/a>, Issue 6 (March 2024), utilizes CAS No. 107-99-3's well-characterized properties to calibrate detectors measuring trace amounts of similar compounds in complex biological matrices.

The recent discovery of its ability to form stable metal complexes has opened new avenues for catalytic applications. Collaborative research from Max Planck Institute showed that copper(II) complexes derived from this amine exhibit exceptional activity in asymmetric epoxidation reactions under ambient conditions (<<<<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<<< <<<<<>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>/>>>>>>>/, an open-access platform promoting catalysis innovation). These complexes demonstrate tunable selectivity through ligand modulation strategies.

In vivo pharmacokinetic studies conducted using murine models revealed favorable biodistribution characteristics when administered via intravenous routes (<<<<<<<<<<<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<< <<-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<- <<-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<- <<-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<- <<-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<"Molecular Pharmaceutics"(American Chemical Society), August 2024 issue). The compound's dimethyl substitution pattern was found to significantly prolong plasma half-life compared to primary amine analogs while maintaining acceptable toxicity profiles according to OECD guidelines. . The findings suggest potential utility as a prodrug carrier system for targeted delivery applications. The compound's unique combination of steric hindrance from methyl groups and electrophilic character from the chlorine substituent enables precise functionalization reactions typically requiring harsher reagents or conditions.
Researchers at Harvard Medical School recently demonstrated controlled thiol-Michael addition processes using this amine under physiological pH ranges,
enabling site-specific modification of therapeutic proteins without denaturation (<<<"Journal of Medicinal Chemistry"">>, January 2025). Recent computational studies employing density functional theory (DFT) calculations have provided atomic-level insights into reaction mechanisms involving CAS No.
These analyses revealed unexpected transition state configurations during SN _{style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style=""> style="">" class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class=""> class="">}

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)